Direct Modification of the Proinflammatory Cytokine Macrophage Migration Inhibitory Factor by Dietary Isothiocyanates

被引:69
作者
Brown, Kristin K. [1 ]
Blaikie, Frances H. [3 ]
Smith, Robin A. J. [3 ]
Tyndall, Joel D. A. [2 ]
Lue, Hongqi
Bernhagen, Juergen
Winterbourn, Christine C. [1 ]
Hampton, Mark B. [1 ]
机构
[1] Univ Otago, Dept Pathol, Free Radical Res Grp, Christchurch 8140, New Zealand
[2] Univ Otago, Natl Sch Pharm, Dunedin 9054, New Zealand
[3] Univ Otago, Dept Chem, Dunedin 9054, New Zealand
关键词
CELL-CYCLE ARREST; FACTOR MIF; PHENETHYL ISOTHIOCYANATE; CANCER CELLS; CRUCIFEROUS VEGETABLES; COVALENT MODIFICATION; ENZYMATIC-ACTIVITY; HEPATOMA-CELLS; APOPTOSIS; SULFORAPHANE;
D O I
10.1074/jbc.M109.047092
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Isothiocyanates are a class of phytochemicals with widely reported anti-cancer and anti-inflammatory activity. However, knowledge of their activity at a molecular level is limited. The objective of this study was to identify biological targets of phenethyl isothiocyanate (PEITC) using an affinity purification approach. An analogue of PEITC was synthesized to enable conjugation to a solid-phase resin. The pleiotropic cytokine macrophage migration inhibitory factor (MIF) was the major protein captured from cell lysates. Site-directed mutagenesis and mass spectrometry showed that PEITC covalently modified the N-terminal proline residue of MIF. This resulted in complete loss of catalytic tautomerase activity and disruption of protein conformation, as determined by impaired recognition by a monoclonal antibody directed to the region that receptors and interacting proteins bind to MIF. The conformational change was supported by in silico modeling. Monoclonal antibody binding to plasma MIF was disrupted in humans consuming watercress, a major dietary source of PEITC. The isothiocyanates have significant potential for development as MIF inhibitors, and this activity may contribute to the biological properties of these phytochemicals.
引用
收藏
页码:32425 / 32433
页数:9
相关论文
共 54 条
[1]   Role of MIF in Inflammation and Tumorigenesis [J].
Bach, Jan-Philipp ;
Rinn, Birgit ;
Meyer, Bernhard ;
Dodel, Richard ;
Bacher, Michael .
ONCOLOGY, 2008, 75 (3-4) :127-133
[2]   Biochemical and nutational investigations of the enzymatic activity of macrophage migration inhibitory factor [J].
Bendrat, K ;
AlAbed, Y ;
Callaway, DJE ;
Peng, T ;
Calandra, T ;
Metz, CN ;
Bucala, R .
BIOCHEMISTRY, 1997, 36 (49) :15356-15362
[3]   Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features [J].
Bernhagen, J ;
Calandra, T ;
Bucala, R .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (3-4) :151-161
[4]   MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment [J].
Bernhagen, Juergen ;
Krohn, Regina ;
Lue, Hongqi ;
Gregory, Julia L. ;
Zernecke, Alma ;
Koenen, Rory R. ;
Dewor, Manfred ;
Georgiev, Ivan ;
Schober, Andreas ;
Leng, Lin ;
Kooistra, Teake ;
Fingerle-Rowson, Guenter ;
Ghezzi, Pietro ;
Kleemann, Robert ;
McColl, Shaun R. ;
Bucala, Richard ;
Hickey, Michael J. ;
Weber, Christian .
NATURE MEDICINE, 2007, 13 (05) :587-596
[5]   MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&
[6]   Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis [J].
Bozza, M ;
Satoskar, AR ;
Lin, GS ;
Lu, B ;
Humbles, AA ;
Gerard, C ;
David, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :341-346
[7]   Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis [J].
Burger-Kentischer, A ;
Goebel, H ;
Seder, R ;
Fraedrich, G ;
Schaefer, HE ;
Dimmeler, S ;
Kleemann, R ;
Bernhagen, J ;
Ihling, C .
CIRCULATION, 2002, 105 (13) :1561-1566
[8]   Convenient synthesis of protected primary amines from nitriles [J].
Caddick, S ;
Haynes, AKD ;
Judd, DB ;
Williams, MRV .
TETRAHEDRON LETTERS, 2000, 41 (18) :3513-3516
[9]   STRUCTURE ACTIVITY RELATIONSHIPS OF NOVEL VASOPRESSIN ANTAGONISTS CONTAINING C-TERMINAL DIAMINOALKANES AND (AMINOALKYL)GUANIDINES [J].
CALLAHAN, JF ;
ASHTONSHUE, D ;
BRYAN, HG ;
BRYAN, WM ;
HECKMAN, GD ;
KINTER, LB ;
MCDONALD, JE ;
MOORE, ML ;
SCHMIDT, DB ;
SILVESTRI, JS ;
STASSEN, FL ;
SULAT, L ;
YIM, NCF ;
HUFFMAN, WF .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (02) :391-396
[10]   Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest [J].
Chiao, JW ;
Wu, HY ;
Ramaswamy, G ;
Conaway, CC ;
Chung, FL ;
Wang, LG ;
Liu, DL .
CARCINOGENESIS, 2004, 25 (08) :1403-1408